1. Medtech Insight
  2. >>Minute Insights

Minute Insight: ViewRay Is Going Out Of Business, Blames Order Backlog

 
• By Reed Miller

ViewRay will continue to maintain its MRI-guided radiation therapy systems at customer sites, but filed for Chapter 11 bankruptcy protection and is planning to sell the business’ assets.

Minute Insight
• Source: Citeline/Alamy

Radiation-guidance company ViewRay, Inc.filed for Chapter 11 bankruptcy protection in a Delaware court and plans to sell its assets.

ViewRay manufactures and markets MRIdian, a proprietary high-resolution magnetic resonance imaging (MRI) technology designed specifically to guide radiation therapy for cancer

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Minute Insights

More from Medtech Insight

Does Makary’s Reorg Choice Mark FDA Turning Point?

 
• By Michael McCaughan

US FDA Commissioner Martin Makary’s disavowal of a proposed reorganization plan may be an important turning point in the Trump Administration. The move does not improve the situation, but may mean the administration stops actively making things worse.

MedTech Europe’s Bisazza Urges Action As US Tariffs Jeopardize Critical Global Supply Chains

 
• By Amanda Maxwell

The intricate assembly of medical devices, often involving over 1,000 globally sourced components, faces severe disruption due to new US tariffs. These barriers could halt production and devastate small and medium-sized enterprises (SMEs), MedTech Europe’s CEO, Oliver Bisazza, warns in an interview with Medtech Insight.

New Treatment For Chronic Facial Pain Could Launch By Fall 2025

 
• By Elizabeth Orr

NeuroOne is preparing to submit its OneRF Trigeminal Nerve Ablation System to the US FDA for treating trigeminal neuralgia, a chronic facial pain condition. CEO Dave Rosa told Medtech Insight that he expects a possible product launch by fall 2025.